free性video西欧极品,伊人依成久久人综合网,中文字幕人妻一区二区三区熟女,男女高潮激烈无遮挡免费观软件 ,成人3d动漫一区二区三区

Basic Info

  • Grade: pharmaceutical grade

    Factory Location: Shanghai

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

    Gilitinib is an oral inhibitor of receptor tyrosine kinases (RTKs), FMS related tyrosine kinases 3 (FLT3, STK1 or FLK2), AXL (UFO or JTK11), and non pigmented lymphoma kinases (ALK or CD246), with potential anti-tumor activity. Gilitinib can bind and inhibit wild-type and mutant FLT3, AXL, and ALK. This may lead to inhibition of signal transduction pathways mediated by FLT3, AXL, and ALK, and reduce tumor cell proliferation in cancer cell types that overexpress these RTKs. FLT3, AXL, and ALK are overexpressed or mutated in various types of cancer cells, playing a crucial role in the growth and survival of tumor cells.
Send your message to this supplier
  • From:
  • To:
    Shanghai Hope-chem Co.,Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    -?Supports?jpg,?jpeg,?png,
    ?gif,?pdf,?doc,?docx,
    ?xls,?xlsx,?txt,?rar?and?zip
    -?Max?upload?3?files;
    ?Max??total?size:?3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service